ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,360.48
0.00%
Brent Oil
82.585
0.00%
Bitcoin
60,883.59
0.14%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. InMed Pharmaceuticals Inc (INM)

  7. InMed Pharmaceuticals Inc (INM) News

InMed Pharmaceuticals (INM)

InMed Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INM
DateTimeSourceHeadlineSymbolCompany
05/03/202420:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
05/03/202420:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
05/03/202420:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
27/02/202420:27Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
22/02/202418:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
21/02/202419:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
13/02/202422:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INMInMed Pharmaceuticals Inc
09/02/202417:34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
19/01/202419:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
16/01/202419:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
26/12/202318:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
26/12/202318:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
26/12/202318:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
26/12/202318:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
26/12/202318:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
26/12/202318:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
26/12/202318:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
26/12/202318:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
26/12/202318:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
21/12/202322:21Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:INMInMed Pharmaceuticals Inc
06/12/202314:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
29/11/202319:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
14/11/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:INMInMed Pharmaceuticals Inc
13/11/202322:05Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:INMInMed Pharmaceuticals Inc
08/11/202322:05Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:INMInMed Pharmaceuticals Inc
02/11/202318:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
27/10/202321:08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INMInMed Pharmaceuticals Inc
27/10/202321:04Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:INMInMed Pharmaceuticals Inc
24/10/202321:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
29/09/202322:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:INM

Your Recent History

LSE
ALL
Atlantic Lithium
LSE
PET
Petrel Resources
LSE
AHT
Ashtead
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved